ITRM20040241A1 - Camptotecine coniugate in posizione 20 con antagonisti delle integrine. - Google Patents

Camptotecine coniugate in posizione 20 con antagonisti delle integrine.

Info

Publication number
ITRM20040241A1
ITRM20040241A1 IT000241A ITRM20040241A ITRM20040241A1 IT RM20040241 A1 ITRM20040241 A1 IT RM20040241A1 IT 000241 A IT000241 A IT 000241A IT RM20040241 A ITRM20040241 A IT RM20040241A IT RM20040241 A1 ITRM20040241 A1 IT RM20040241A1
Authority
IT
Italy
Prior art keywords
camptotecine
integrine
antagonists
conjugated
integrine antagonists
Prior art date
Application number
IT000241A
Other languages
English (en)
Inventor
Domenico Alloatti
Pozzo Alma Dal
Sabrina Dallavalle
Giuseppe Giannini
Lucio Merlini
Ming Hong Ni
Sergio Penco
Claudio Pisano
Maria Ornella Tinti
Loredana Vesci
Franco Zunino
Original Assignee
Ist Naz Stud Cura Dei Tumori
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Naz Stud Cura Dei Tumori, Sigma Tau Ind Farmaceuti filed Critical Ist Naz Stud Cura Dei Tumori
Priority to IT000241A priority Critical patent/ITRM20040241A1/it
Publication of ITRM20040241A1 publication Critical patent/ITRM20040241A1/it
Priority to MXPA06012886A priority patent/MXPA06012886A/es
Priority to CA002562572A priority patent/CA2562572A1/en
Priority to EP05743015A priority patent/EP1747019A2/en
Priority to BRPI0511037-8A priority patent/BRPI0511037A/pt
Priority to JP2007512735A priority patent/JP2007537244A/ja
Priority to US11/596,189 priority patent/US20070232639A1/en
Priority to PCT/IT2005/000261 priority patent/WO2005110487A2/en
Priority to AU2005243834A priority patent/AU2005243834A1/en
Priority to TW094114403A priority patent/TW200538125A/zh
Priority to CNA2005800152323A priority patent/CN101010103A/zh
Priority to ARP050101933A priority patent/AR049275A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IT000241A 2004-05-13 2004-05-13 Camptotecine coniugate in posizione 20 con antagonisti delle integrine. ITRM20040241A1 (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT000241A ITRM20040241A1 (it) 2004-05-13 2004-05-13 Camptotecine coniugate in posizione 20 con antagonisti delle integrine.
CNA2005800152323A CN101010103A (zh) 2004-05-13 2005-05-04 在20位与整联蛋白拮抗剂缀合的喜树碱衍生物
BRPI0511037-8A BRPI0511037A (pt) 2004-05-13 2005-05-04 derivados de camptotecinas conjugados na posição 20 com antagonistas de integrina
CA002562572A CA2562572A1 (en) 2004-05-13 2005-05-04 Camptothecin derivatives conjugated in position 20 with integrin antagonists
EP05743015A EP1747019A2 (en) 2004-05-13 2005-05-04 Camptothecin derivatives conjugated in position 20 with integrin antagonists
MXPA06012886A MXPA06012886A (es) 2004-05-13 2005-05-04 Derivados de camptotecina conjugados en posicion 20 con antagonistas de integrina.
JP2007512735A JP2007537244A (ja) 2004-05-13 2005-05-04 ２０位にてインテグリンアンタゴニストと接合したカンプトテシン誘導体
US11/596,189 US20070232639A1 (en) 2004-05-13 2005-05-04 Camptothecin Derivatives Conjugated in Position 20 with Integrin Antagonists
PCT/IT2005/000261 WO2005110487A2 (en) 2004-05-13 2005-05-04 Camptothecin derivatives conjugated in position 20 with integrin antagonists
AU2005243834A AU2005243834A1 (en) 2004-05-13 2005-05-04 Camptothecin derivatives conjugated in position 20 with integrin antagonists
TW094114403A TW200538125A (en) 2004-05-13 2005-05-04 Camptothecin derivatives conjugated in position 20 with integrin antagonists
ARP050101933A AR049275A1 (es) 2004-05-13 2005-05-12 Derivados de camptotecina conjugada en posicion 20 con antagonistas de la integrina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000241A ITRM20040241A1 (it) 2004-05-13 2004-05-13 Camptotecine coniugate in posizione 20 con antagonisti delle integrine.

Publications (1)

Publication Number Publication Date
ITRM20040241A1 true ITRM20040241A1 (it) 2004-08-13

Family

ID=35124307

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000241A ITRM20040241A1 (it) 2004-05-13 2004-05-13 Camptotecine coniugate in posizione 20 con antagonisti delle integrine.

Country Status (12)

Country Link
US (1) US20070232639A1 (it)
EP (1) EP1747019A2 (it)
JP (1) JP2007537244A (it)
CN (1) CN101010103A (it)
AR (1) AR049275A1 (it)
AU (1) AU2005243834A1 (it)
BR (1) BRPI0511037A (it)
CA (1) CA2562572A1 (it)
IT (1) ITRM20040241A1 (it)
MX (1) MXPA06012886A (it)
TW (1) TW200538125A (it)
WO (1) WO2005110487A2 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2129402A2 (en) * 2007-02-16 2009-12-09 KTB Tumorforschungsgesellschaft mbH Receptor and antigen targeted prodrug
ES2605939T3 (es) * 2012-01-27 2017-03-17 F. Hoffmann-La Roche Ag Conjugados de antagonistas de la integrina para una administración dirigida a células que expresan alfa-V-beta-3
CN105399757A (zh) * 2015-12-29 2016-03-16 遵义医学院 酸敏感型喜树碱-20位去甲斑蝥酸酯衍生物及其抗肿瘤应用
CN111068068A (zh) * 2019-12-04 2020-04-28 云南民族大学 一种rgd多肽-喜树碱多肽药物偶联物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19815812A1 (de) * 1998-04-08 1999-10-14 Bayer Ag Modifizierte Cytostatika
DE69901379T2 (de) * 1999-03-09 2002-11-07 Istituto Nazionale Per Lo Studio E La Cura Dei Tumori, Mailand/Milano Camptothecin-Derivate mit Antitumor-Wirkung
US6207832B1 (en) * 1999-04-09 2001-03-27 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
WO2001017563A2 (en) * 1999-09-08 2001-03-15 Bayer Aktiengesellschaft Integrin-mediated drug targeting

Also Published As

Publication number Publication date
AR049275A1 (es) 2006-07-12
US20070232639A1 (en) 2007-10-04
EP1747019A2 (en) 2007-01-31
AU2005243834A1 (en) 2005-11-24
CN101010103A (zh) 2007-08-01
WO2005110487A3 (en) 2007-02-15
TW200538125A (en) 2005-12-01
BRPI0511037A (pt) 2007-11-27
CA2562572A1 (en) 2005-11-24
MXPA06012886A (es) 2007-02-15
JP2007537244A (ja) 2007-12-20
WO2005110487A2 (en) 2005-11-24

Similar Documents

Publication Publication Date Title
DE602006011289D1 (de) Muster mit geringerem abstand im zusammenhang mit photolithographischen merkmalen
DE602005009657D1 (de) Übertragung in zwei Betriebsarten
DOP2006000278A (es) Glicosilación en la región variable
DE112006001565A5 (de) Nanopartikel-Wirkstoff-Konjugate
ATE506362T1 (de) 1-aza-bicycloä3.3.1ünonane
ITRM20040240A1 (it) Camptotecine coniugate in posizione 7 con antagonisti delle integrine.
DE112006003324T8 (de) Abtastvorrichtung mit modularen Teilen
FI20045026A0 (fi) Kytkinlaite
NO20054964D0 (no) Drivstoffdryppfanger
FI20041641L (fi) Sovitelma silmänpainemittarissa
ITRM20040241A1 (it) Camptotecine coniugate in posizione 20 con antagonisti delle integrine.
ATE447977T1 (de) Biotin-diamino-derivate und ihre konjugate mit makrocyclischen chelationsmitteln
DE602006018617D1 (de) Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivaten
FI20040068A0 (fi) Kytkinlaite
EP1819352A4 (en) PHARMACEUTICAL COMPOSITIONS FROM CARAPA GUIANENSIS
ITRM20040242A1 (it) "7-t-butossiimminometilcamptotecina coniugata in posizione 20 con antagonisti delle integrine.
EP1907843A4 (en) Uniformly conjugated serine hydrolases
FR2892125B1 (fr) Composition a base d'hydrofluorocarbures
ES2365717T5 (es) Vacunacion meningococica conjugada.
FR2881644B1 (fr) Composition cosmetique a texture fine.
FI20045499A0 (fi) Järjestely oskillointilaitteessa
NL1026779A1 (nl) Contactpen.
ITTS20040008U1 (it) La macchina delle coccole
FI20041580L (fi) Sovitelma perälaatikossa
FI20040423A0 (fi) Järjestely hississä